Related Experiment Videos
Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism
Pharmacological Research Communications
|December 1, 1984
Summary
Caerulein, a Cholecystokinin (CCK) analogue, significantly reduced rat locomotor activity. This hypomotility occurred without altering dopamine levels or release, suggesting a complex interaction with the dopaminergic system.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Cholecystokinin (CCK) and dopaminergic transmission are functionally related.
- Caerulein is a stable analogue of CCK.
Purpose of the Study:
- To investigate the effects of Caerulein on rat locomotor activity.
- To examine the impact of Caerulein on biochemical markers of dopaminergic transmission.
Main Methods:
- Rats were injected with Caerulein and their locomotor activity was measured.
- Dopamine and DOPAC levels were analyzed in striatum and nucleus accumbens.
- Spontaneous and K+ evoked dopamine release was assessed.
Main Results:
- Caerulein (0.25 µg/Kg) almost completely reduced locomotor activity.
- No significant changes in DOPAC content or dopamine release were observed.
- Higher Caerulein doses slightly decreased DOPAC concentrations.
- Haloperidol potentiated Caerulein-induced hypomotility without affecting dopaminergic metabolism.
Conclusions:
- A significant pharmacological interaction exists between Caerulein and dopamine antagonists.
- The precise site of this interaction, potentially beyond dopamine terminals, requires further investigation.